Chronic sequelae of immune-related adverse events
While acute management of irAEs has improved over the past decade, there is a major gap in understanding and addressing their chronic sequelae. Challenges in studying these sequelae include the complexity of cancer care, overlapping clinical presentations, and previously, a lack of long-term data. Continued research from large multicenter studies and dedicated databases can identify high-risk patients, inform risk-benefit discussions, refine management strategies, and pave the way for evidence-based, long-term care.
Authors
- Sean Ngo (ORCID: https://orcid.org/0000-0001-7298-2662)
- AJAY SHESHADRI
- E. Roeland
- Ata S. Moshiri (ORCID: https://orcid.org/0000-0001-6684-4503)
- Carolina Colli Cruz (ORCID: https://orcid.org/0000-0001-7065-3769)
- Thein Hlaing Oo (ORCID: https://orcid.org/0000-0002-5201-731X)
- Faraz Jafri (ORCID: https://orcid.org/0000-0002-6568-8120)
- Pauline Funchain (ORCID: https://orcid.org/0000-0002-7568-8626)
- Rachel Mortan (ORCID: https://orcid.org/0009-0003-0698-9745)
- Stephanie Kim
- Hao Chi Zhang (ORCID: https://orcid.org/0000-0003-0330-0167)
- Raakhi Menon
- Tomas G. Neilan
- Andres Urias Rivera
- Anirudha Chatterjee
- Devin M. Garza
- Jarrett Rong
- Hamza Salim
- Marc Ernstoff
Institutions
- National Institutes of Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- Oregon Health & Science University (US)
- Baylor College of Medicine (US)
- Massachusetts General Hospital (US)
- Stanford Medicine (US)
- The University of Texas Health Science Center (US)
- The University of Texas Medical Branch at Galveston (US)
- New York University (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1080/14740338.2026.2635994
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00